Matthew Hershenhorn

Stock Analyst at Oppenheimer

(2.71)
# 2,124
Out of 5,048 analysts
1
Total ratings
100%
Success rate
21.23%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $135.75
Upside: +36.28%